Inclusion of non-prescription medicines in essential lists: a cross-sectional study
International Journal of Pharmacy Practice · 2026
DOI: 10.1093/ijpp/riag001 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Pharmacy Practice, 2026. Verfasst von Camila Heredia und 2 weiteren Autor:innen. Beteiligte Einrichtung: MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontar…. Hauptthemen laut MEDLINE: Nonprescription Drugs, Drugs, Essential, Health Services Accessibility. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objectives
Over and behind-the-counter medicines are among the most used medicines globally, but their availability differs across countries. While they offer convenient access and fill critical gaps in healthcare, their misuse or improper administration poses risks. This study aimed to assess the inclusion patterns of over-the-counter (OTC) and behind-the-counter (BTC) medicines on essential medicines lists worldwide and examine their effect on public health in terms of accessibility and affordability, as well as the common medical conditions they are intended to address. Additionally, the study examines the regulatory frameworks governing these medicines to understand how healthcare systems balance accessibility with safety. Findings are intended to inform policy decisions aimed at optimizing medicine availability while minimizing potential harms.
Methods
This cross-sectional study involved a comparative analysis of essential medicines lists from 158 countries with publicly accessible lists. Main outcomes included the proportion of essential medicines classified as OTC or BTC, variations in their availability across countries, and a comparison with the World Health Organization’s model list. Key findings Findings suggest significant variability in the availability of both prescription and non-prescription medicines across countries. While some nations prioritize accessibility by classifying a larger proportion of essential medicines as OTC, others implement stricter regulations to mitigate risks of misuse.
Conclusions
This study highlights the critical role of regulatory frameworks in shaping access to medicines and ensuring their safe use. Understanding global patterns in over or behind-the-counter medicine availability and their inclusion in essential medicines lists can inform policy decisions to optimize healthcare delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario M5B 1T8, Canada.
- Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, 500 University Ave, Toronto, Ontario M5G 1V7, Canada.
ORCID-Profile: Navindra Persaud
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Heredia, C., Haq, M. Z. U., & Persaud, N. (2026). Inclusion of non-prescription medicines in essential lists: a cross-sectional study. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riag001
Vancouver
Heredia C, Haq MZU, Persaud N. Inclusion of non-prescription medicines in essential lists: a cross-sectional study. International Journal of Pharmacy Practice. 2026. doi:10.1093/ijpp/riag001
BibTeX
@article{Heredia2026,
author = {Heredia, Camila and Haq, Moizza Zia Ul and Persaud, Navindra},
title = {Inclusion of non-prescription medicines in essential lists: a cross-sectional study},
journal = {International Journal of Pharmacy Practice},
year = {2026},
doi = {10.1093/ijpp/riag001}
}
EUVIMED